Convergence Medical’s VO1 Robot Gains Momentum with Global Investor Backing

VO1
Photo credit: Convergence Medical/convergenceortho.com

Brisbane City’s Convergence Medical, has secured $5 million in funding, with support from global investors like US-based Avicella Capital. The investment will fast-track the commercialisation of its groundbreaking VO1 arthroscopic surgical robot and drive expansion into the US market.


Read: Urgent Blood Donation Appeal: Here’s Where to Donate in Brisbane CBD


The investment positions the company, headquartered on Queen Street, at a valuation exceeding $30 million, highlighting its growing influence in the global healthcare sector. Early angel, pre-seed, and seed investors have seen significant returns on their initial support for the company, founded just three years ago.

The VO1 surgical robot (Photo credit: Convergence Medical/convergenceortho.com)

Increase Your Business Profile

The VO1 robot is poised to disrupt the $6.1 billion global arthroscopic surgery market by enhancing precision and reducing strain on surgeons during procedures. Arthroscopic surgery treats over 50 million joint injuries worldwide each year. CEO Dr. Chris Jeffery, who has a strong track record in orthopaedic innovation, shared his excitement about this milestone.

Join Mailing List

Photo credit: Convergence Medical/convergenceortho.com

Tower Ad

“This funding enables us to accelerate our growth and bring our transformative technology to hospitals and surgeons around the globe,” said Dr. Jeffery. “Our mission is to create more efficient, effective solutions that support medical professionals and improve patient outcomes worldwide.”

The VO1 robot gained a significant boost in December 2023, being accepted into the US Food and Drug Administration’s (FDA) Breakthrough Devices Program, a prestigious recognition granted to fewer than 3 percent of submissions. This program will fast-track the device’s path to market.

Dr Gennady Bratslavsky, co-founder and partner of Avicella Capital, expressed confidence in the Brisbane-based company’s potential. “Convergence Medical, under the leadership of Chris Jeffery, is a pioneer in MedTech innovation,” Dr Bratslavsky noted.

Photo credit: Convergence Medical/convergenceortho.com

The funding will be utilised to scale production, develop global partnerships, and advance research and development. A soft launch of the VO1 robot is anticipated soon.

Anthony Ryan, CEO of the Brisbane Economic Development Agency (BEDA), emphasized the significance of this achievement. “Brisbane’s MedTech sector is experiencing remarkable growth, unlocking incredible opportunities for innovation and investment,” said Mr. Ryan. He added that Convergence Medical’s success showcases the city’s ability to lead in medical technology advancements.


Read: Brisbane City Outreach Van Drives Support for Homeless Women


Convergence Medical’s presence in Brisbane City continues to attract talent and investment, cementing its role as a hub for MedTech innovation.

Published 24-January-2025